PRESS RELEASE published on 09/04/2024 at 22:30, 2 years 2 months ago DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
BRIEF published on 08/02/2024 at 22:35, 2 years 3 months ago DBV Technologies : Informations au 31 juillet 2024 sur le nombre d'actions et de droits de vote Droits De Vote Capital Social AMF DBV Technologies NYSE Euronext Paris
BRIEF published on 08/02/2024 at 22:35, 2 years 3 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 2 years 3 months ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024 Nombre total des droits de vote et d’actions au 31 juillet 2024 pour NYSE Euronext Paris (Code ISIN: FR 0010417345) : 96 498 927 actions, 96 214 457 droits de vote Autorité Des Marchés Financiers Droits De Vote Capital Social Actions NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 2 years 3 months ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
BRIEF published on 07/30/2024 at 23:35, 2 years 3 months ago DBV Technologies met à disposition son Rapport Financier Semestriel 2024 AMF Rapport Financier DBV Technologies Allergies Alimentaires Viaskin™
BRIEF published on 07/30/2024 at 23:35, 2 years 3 months ago DBV Technologies makes its 2024 Half-Year Financial Report available AMF Financial Report DBV Technologies Food Allergy Viaskin™
PRESS RELEASE published on 07/30/2024 at 23:30, 2 years 3 months ago DBV Technologies publie son Rapport Financier Semestriel 2024 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2024 et annonce sa disponibilité pour consultation en ligne ou par demande Biopharmaceutique Rapport Financier DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE published on 07/30/2024 at 23:30, 2 years 3 months ago DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2024 Half-Year Report with AMF and offers access via website or request. Company develops treatments for food allergies using Viaskin platform AMF DBV Technologies Food Allergies 2024 Half-Year Report Viaskin Platform
Published on 11/09/2026 at 14:00, 1 minute ago Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 13:30, 31 minutes ago Meta Critical Minerals Accepts Invitation to Join Critical Minerals Consortium at the U.S. Military Academy at West Point
Published on 11/09/2026 at 13:01, 1 hour ago CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
Published on 11/09/2026 at 13:00, 1 hour 1 minute ago Nextech3D.ai Closes $720,000 Management-Led Private Placement
Published on 11/09/2026 at 13:45, 16 minutes ago Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc
Published on 11/09/2026 at 13:35, 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/09/2026 at 13:05, 56 minutes ago AUCTION OPENS FOR MICHAEL JACKSON, PRINCESS DIANA & POP CULTURE LEGENDS AS JULIEN'S HEADS TO ABU DHABI
Published on 11/09/2026 at 13:00, 1 hour 1 minute ago Original-Research: Reply S.p.A. (von GBC AG): BUY
Published on 11/09/2026 at 10:32, 3 hours 29 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 3 hours 29 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 7 hours 1 minute ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 7 hours 1 minute ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 7 hours 1 minute ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
